Clinical trial
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of Persistent Symptoms in Patients With Celiac Disease on a GFD
NCT03569007 is registered in ClinicalTrials.gov with 9 Meters Biopharma, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of Persistent Symptoms in Patients With Celiac Disease on a GFD
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- May 29, 2019
- Completion date
- July 21, 2022
- Enrollment
- 307 (actual)
- Sites
- 160
Conditions
As the registry lists them; a condition with its own page is linked.